Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis.

Brunella Posteraro Elena De CarolisMarianna CriscuoloStelvio BallantiGiulia De AngelisMaria Ilaria Del PrincipeMario DeliaNicola FracchiollaFrancesco MarchesiGianpaolo NadaliMarco PicardiAnna Lina PiccioniLuisa VergaAnna CandoniAlessandro Busca Sanguinetti Maurizio Livio Paganonull null

Published in: Mycoses (2020)

Optimisation of prophylactic strategies is necessary to limit the occurrence of breakthrough candidaemia and, importantly, the emergence of fluconazole-resistant NCAC isolates' infections in haematological malignancy patients.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
risk assessment
candida albicans
patient reported outcomes